Shields Lisa B E, Seifert Tad, Shelton Brent J, Plato Brian M
Norton Neuroscience Institute, Norton Healthcare, Louisville, KY.
The Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY, USA.
Neurol Int. 2019 Jun 19;11(2):8079. doi: 10.4081/ni.2019.8079. eCollection 2019 Jun 18.
Chronic migraine is a frequent and debilitating condition affecting 14% of the general population. This prospective observational pilot study investigated whether men with chronic migraine have lower than expected total serum testosterone levels. We identified 14 men ages 26-51 at our Institution who fulfilled the ICHD-3b criteria for chronic migraine and obtained serum total testosterone levels. The mean total testosterone level in our 14 patients was 322 ng/dL (range: 120-542 ng/dL) which is in the lower 5% of the reference range for our laboratory (300-1080 ng/dL). Men with chronic migraine had lower total testosterone levels compared to published agematched normative median values by a median difference of 62 ng/dL (P=0.0494). This finding suggests that hypothalamic regulation is altered in patients with chronic migraine. Further studies are warranted to determine whether testosterone supplementation in men with chronic migraine reduces the number of headaches or the associated symptoms of hypogonadism.
慢性偏头痛是一种常见且使人衰弱的疾病,影响着14%的普通人群。这项前瞻性观察性试点研究调查了患有慢性偏头痛的男性血清总睾酮水平是否低于预期。我们在本机构中确定了14名年龄在26至51岁之间符合国际头痛疾病分类第三版beta版(ICHD-3b)慢性偏头痛标准的男性,并获取了他们的血清总睾酮水平。我们的14名患者的平均总睾酮水平为322 ng/dL(范围:120 - 542 ng/dL),处于我们实验室参考范围(300 - 1080 ng/dL)的较低5%。与已发表的年龄匹配的正常中位值相比,患有慢性偏头痛的男性总睾酮水平较低,中位数差异为62 ng/dL(P = 0.0494)。这一发现表明慢性偏头痛患者的下丘脑调节发生了改变。有必要进行进一步研究以确定对患有慢性偏头痛的男性补充睾酮是否能减少头痛次数或性腺功能减退的相关症状。